Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging

Radiology

Volumn 265, Issue 3, 2012, Pages 696-706

  Parsian, Sana ^a   Rahbar, Habib ^a   Allison, Kimberly H ^a   DeMartini, Wendy B ^a   Olson, Matthew L ^a   Lehman, Constance D ^a   Partridge, Savannah C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADODIAMIDE;

ADULT; AGED; APOCRINE METAPLASIA; APPARENT DIFFUSION COEFFICIENT; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST BIOPSY; BREAST FIBROADENOMA; BREAST FIBROSIS; BREAST LESION; COHORT ANALYSIS; CONSTANTS AND COEFFICIENTS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPH NODE; MAJOR CLINICAL STUDY; MASTITIS; METAPLASIA; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOPSY; BREAST DISEASES; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FALSE POSITIVE REACTIONS; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 84870009573     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112672     Document Type: Article

References (59)

1. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351(5):427-437.
2. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multiinstitution breast cancer screening study. Radiology 2007;244(2):381-388. (Pubitemid 47080869)
3. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57(2):75-89. (Pubitemid 46535708)
4. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292(11):1317-1325. (Pubitemid 39223222)
5. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004;233(3):830-849.
6. Hollingsworth AB, Stough RG, O'Dell CA, Brekke CE. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg 2008;196(3):389-397.
7. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007;356(13):1295-1303. (Pubitemid 46513295)
8. Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 2005;92(1):32-38. (Pubitemid 41416426)
9. Kuhl CK. Current status of breast MR imaging. II. Clinical applications. Radiology 2007;244(3):672-691. (Pubitemid 47292079)
10. Kuhl C. The current status of breast MR imaging. I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007;244(2):356-378. (Pubitemid 47080868)
11. Baltzer PA, Dietzel M, Vag T, et al. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. Rofo 2011;183(5):441-447.
12. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16(2):172-178. (Pubitemid 34810055)
13. Tozaki M, Fukuma E. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? AJR Am J Roentgenol 2009;193(3):840-849.
14. Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 2006;24(2):319-324. (Pubitemid 44188557)
15. Woodhams R, Matsunaga K, Kan S, et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005;4(1):35-42.
16. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008;7(1):23-29.
17. Lo GG, Ai V, Chan JK, et al. Diffusionweighted magnetic resonance imaging of breast lesions: first experiences at 3 T. J Comput Assist Tomogr 2009;33(1):63-69.
18. Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 2010;31(3):562-570.
19. Yabuuchi H, Matsuo Y, Okafuji T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging 2008;28(5):1157-1165.
20. Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 2009;193(6):1716-1722.
21. Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992;159(3):591-599.
22. Kinoshita T, Yashiro N, Ihara N, Funatu H, Fukuma E, Narita M. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr 2002;26(6):1042-1046. (Pubitemid 36076728)
23. Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 2007;17(10):2646-2655.
24. Sinha S, Lucas-Quesada FA, Sinha U, De-Bruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002;15(6):693-704. (Pubitemid 34606504)
25. Wenkel E, Geppert C, Schulz-Wendtland R, et al. Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. Acad Radiol 2007;14(9):1077-1083. (Pubitemid 47260686)
26. Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005;29(5):644-649. (Pubitemid 41395779)
27. Yoshikawa MI, Ohsumi S, Sugata S, et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008;26(4):222-226. (Pubitemid 351754726)
28. Partridge SC, Ziadloo A, Murthy R, et al. Diffusion tensor MRI: preliminary anisotropy measures and mapping of breast tumors. J Magn Reson Imaging 2010;31(2):339-347.
29. Partridge SC, Mullins CD, Kurland BF, et al. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 2010;194(6):1664-1673.
30. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007;8(5):390-396.
31. Kim SH, Cha ES, Kim HS, et al. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging 2009;30(3):615-620.
32. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43(6):828-836. (Pubitemid 30387603)
33. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9(1):53-60. (Pubitemid 29068231)
34. Partridge SC, Rahbar H, Murthy R, et al. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magn Reson Med 2011;65(6):1759-1767.
35. Ei Khouli RH, Jacobs MA, Mezban SD, et al. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology 2010;256(1):64-73.
36. Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol 2011;196(1):210-217.
37. Ikeda DM, Hylton NM, Kuhl CK, et al. BIRADS: magnetic resonance imaging. In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al, eds. Breast Imaging Reporting and Data System: ACR BI-RADS - Breast Imaging Atlas. Reston, Va: American College of Radiology, 2003.
38. Satake H, Nishio A, Ikeda M, et al. Predictive value for malignancy of suspicious breast masses of BI-RADS categories 4 and 5 using ultrasound elastography and MR diffusion-weighted imaging. AJR Am J Roentgenol 2011;196(1):202-209.
39. Woodhams R, Kakita S, Hata H, et al. Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings. AJR Am J Roentgenol 2009;193(1):260-266.
40. Heusner TA, Kuemmel S, Koeninger A, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 2010;37(6):1077-1086.
41. Nakai G, Matsuki M, Harada T, et al. Evaluation of axillary lymph nodes by diffusionweighted MRI using ultrasmall superparamagnetic iron oxide in patients with breast cancer: initial clinical experience. J Magn Reson Imaging 2011;34(3):557-562.
42. Belli P, Costantini M, Bufi E, Magistrelli A, La Torre G, Bonomo L. Diffusion-weighted imaging in breast lesion evaluation. Radiol Med (Torino) 2010;115(1):51-69.
43. Imamura T, Isomoto I, Sueyoshi E, et al. Diagnostic performance of ADC for non-masslike breast lesions on MR imaging. Magn Reson Med Sci 2010;9(4):217-225.
44. Love SM, Gelman RS, Silen W. Sounding board: fibrocystic "disease" of the breast-a nondisease? N Engl J Med 1982;307(16):1010-1014. (Pubitemid 12018963)
45. Le Bihan D, Poupon C, Amadon A, Lethimonnier F. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 2006;24(3):478-488. (Pubitemid 44320549)
46. Mukherjee P, Chung SW, Berman JI, Hess CP, Henry RG. Diffusion tensor MR imaging and fiber tractography: technical considerations. AJNR Am J Neuroradiol 2008;29(5):843-852. (Pubitemid 351684953)
47. Zhuang J, Hrabe J, Kangarlu A, et al. Correction of eddy-current distortions in diffusion tensor images using the known directions and strengths of diffusion gradients. J Magn Reson Imaging 2006;24(5):1188-1193. (Pubitemid 44658261)
48. Matsuoka A, Minato M, Harada M, et al. Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 2008;26(1):15-20. (Pubitemid 351928143)
49. Melhem ER, Itoh R, Jones L, Barker PB. Diffusion tensor MR imaging of the brain: effect of diffusion weighting on trace and anisotropy measurements. AJNR Am J Neuroradiol 2000;21(10):1813-1820.
50. Woodhams R, Ramadan S, Stanwell P, et al. Diffusion-weighted imaging of the breast: principles and clinical applications. Radio-Graphics 2011;31(4):1059-1084.
51. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188(6):1622-1635. (Pubitemid 46866868)
52. Jin G, An N, Jacobs MA, Li K. The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. Acad Radiol 2010;17(4):456-463.
53. Peters NH, Vincken KL, van den Bosch MA, Luijten PR, Mali WP, Bartels LW. Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values. J Magn Reson Imaging 2010;31(5):1100-1105.
54. Pereira FP, Martins G, Figueiredo E, et al. Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values. AJR Am J Roentgenol 2009;193(4):1030-1035.
55. Chen G, Jespersen SN, Pedersen M, Pang Q, Horsman MR, Stødkilde-Jørgensen H. Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging 2005;23(5):685-689. (Pubitemid 41033047)
56. Fitzek C, Mentzel HJ, Fitzek S, Sauner D, Kaiser WA, Reichenbach JR. Echoplanar diffusion-weighted MRI with intravenous gadolinium-DTPA. Neuroradiology 2003;45(9):592-597. (Pubitemid 37236178)
57. Ogura A, Hayakawa K, Miyati T, Maeda F. The effect of susceptibility of gadolinium contrast media on diffusion-weighted imaging and the apparent diffusion coefficient. Acad Radiol 2008;15(7):867-872. (Pubitemid 352033541)
58. Liu X, Zhou L, Peng W, Qian M. Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging. Acta Radiol 2011;52(5):575-580.
59. Yuen S, Yamada K, Goto M, Nishida K, Takahata A, Nishimura T. Microperfusion-induced elevation of ADC is suppressed after contrast in breast carcinoma. J Magn Reson Imaging 2009;29(5):1080-1084.